Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 2 | 191 | 77 | 0.1154 | 0.1255 | 0.4031 | 0.4181 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 3 | 196 | 90 | 0.1073 | 0.1255 | 0.4592 | 0.4181 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 1 | 250 | 98 | 0.1539 | 0.1255 | 0.3920 | 0.4181 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 3 | 255 | 100 | 0.1569 | 0.2379 | 0.3922 | 0.3676 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 3 | 285 | 67 | 0.2141 | 0.2478 | 0.2351 | 0.2217 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 1 | 290 | 89 | 0.2035 | 0.2184 | 0.3069 | 0.3304 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 0.316 | uM | 72 | hr | 2 | 296 | 50 | 0.2416 | 0.2619 | 0.1689 | 0.2293 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 1.000 | uM | 72 | hr | 3 | 309 | 93 | 0.2121 | 0.3656 | 0.3010 | 0.2907 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 3 | 319 | 126 | 0.1954 | 0.2184 | 0.3950 | 0.3304 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 3 | 324 | 106 | 0.2207 | 0.2531 | 0.3272 | 0.3208 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 3 | 333 | 119 | 0.2167 | 0.3044 | 0.3574 | 0.3533 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 0.316 | uM | 72 | hr | 1 | 337 | 88 | 0.2445 | 0.2619 | 0.2611 | 0.2293 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 2 | 338 | 89 | 0.2445 | 0.2478 | 0.2633 | 0.2217 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 2 | 342 | 114 | 0.2308 | 0.2379 | 0.3333 | 0.3676 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 345 | 95 | 0.1995 | 0.3311 | 0.2754 | 0.2885 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 1 | 348 | 58 | 0.2848 | 0.2478 | 0.1667 | 0.2217 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 2 | 356 | 103 | 0.2562 | 0.2184 | 0.2893 | 0.3304 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 3 | 366 | 188 | 0.1802 | 0.2143 | 0.5137 | 0.4559 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 2 | 367 | 115 | 0.2551 | 0.2531 | 0.3134 | 0.3208 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 3 | 368 | 66 | 0.3058 | 0.4404 | 0.1793 | 0.1902 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 376 | 115 | 0.2082 | 0.2628 | 0.3059 | 0.2739 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 377 | 155 | 0.1368 | 0.1471 | 0.4111 | 0.4142 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 3 | 378 | 104 | 0.0869 | 0.1027 | 0.2751 | 0.2808 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 1 | 395 | 154 | 0.2440 | 0.2143 | 0.3899 | 0.4559 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 2 | 403 | 187 | 0.2187 | 0.2143 | 0.4640 | 0.4559 |